The U.S. Gadolinium-based Contrast Media Market was $456.32 Mn in 2020, and it is highly expected to reach $678.40 Mn by 2030. It is eventually growing at a commendable high compound of annual growth rate CAGR of 4.0% between 2020-2030, as per the latest market research report titled U.S. Gadolinium-based Contrast Media Market – Industry analysis, size, share, growth, trends and forecast, 2020 – 2030.
The growth of this market is mainly because of the advancements in technologies and long term chronic diseases. The growing prevalence of the complex morbidities and label expansion like acquisitions and mergers by the key players. Around six out of ten people in the U.S. do suffer from chronic disease and four out of ten people suffer from comorbidity. It is the Chronic disease that lead to death and disability in the country. So these are the main factors that will help to accelerate the growth of this market.
The primary key players in U.S. Gadolinium-based Contrast Media Market include Bayer AG, GE Healthcare, Guerbet, Lantheus Medical Imaging, Inc., Bracco Diagnostic, Inc., Trivitron Healthcare.
Get Sample Copy With Covid19 Impact Analysis: https://www.sheeranalyticsandinsights.com/request-sample/us-gadolinium-based-contract-media-market-21
Major Players In U.S. Gadolinium-based Contract Media Market
Some of the major players in the U.S. Gadolinium-based Contrast Media Market include Bayer AG, GE Healthcare, Guerbet, Lantheus Medical Imaging, Inc., Bracco Diagnostic, Inc., and Trivitron Healthcare.
The U.S. Gadolinium-based Contract Media Market Has Been Segmented Into:
- Extracellular Agents
- Blood Pool Agents
- Hepatobiliary Agents
- Other (Musculoskeletal)
- North America
- Asia Pacific
- Latin America
- Middle East & Africa